BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20514905)

  • 1. [Current opinions on pathogenesis, diagnostic procedures and management of gastric neuroendocrine tumors].
    Gilis-Januszewska A; Baczyńska E; Szybiński P; Sowa-Staszczak A; Trofimiuk M; Pach D; Tomaszewska R; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(12):1052-61. PubMed ID: 20514905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastric carcinoid--pathogenesis and treatment].
    Bründler R; Gebbers JO; Criblez D
    Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Pathogenesis and management of gastric carcinoid tumours.
    Burkitt MD; Pritchard DM
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1305-20. PubMed ID: 17059512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine tumours of the stomach.
    Delle Fave G; Capurso G; Milione M; Panzuto F
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of ECL cell tumors.
    Cadiot G; Cattan D; Mignon M
    Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
    Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
    Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumours of the stomach.
    Bordi C
    Pathol Res Pract; 1995 May; 191(4):373-80. PubMed ID: 7479354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine carcinoma associated with atrophic gastritis in the norwegian lundehund.
    Qvigstad G; Kolbjørnsen Ø; Skancke E; Waldum HL
    J Comp Pathol; 2008 Nov; 139(4):194-201. PubMed ID: 18817920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic disease in patients with neuroendocrine tumors.
    Niederhuber JE; Fojo T
    Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.